Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial.
| Autor: | Pacilio, C.1, Morabito, A.2, Nuzzo, F.1, Gravina, A.1, Labonia, V.1, Landi, G.1, Rossi, E.1, De Maio, E.2, Di Maio, M.2, D'aiuto, G.3, Botti, G.4, Normanno, N.5, Chiodini, P.6, Gallo, C.6, Perrone, F.2 perrone@uosc.fondazionepascale.it, de Matteis, A.1, NCI-Naples Breast Cancer Group (CORPORATE AUTHOR) |
|---|---|
| Zdroj: | British Journal of Cancer. 5/8/2006, Vol. 94 Issue 9, p1233-1236. 4p. 3 Charts, 1 Graph. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|